Stop PREP to stop neurodegeneration?

We are studying the role of prolyl oligopeptidase (PREP, formerly known as POP) on disease progression and neuronal toxicity in neurodegenerative disorders with protein aggregation. These disorders include several serious diseases such as Alzheimer’s and Parkinson’s diseases, and several more rare neurodegenerative conditions. Based on PREP inhibitors, we are developing novel and disease-modifying drug therapies to stop neuronal death in Alzheimer's and Parkinson's diseases.
Find out more about PREP research

Our research

Interested in collaborating with us or investing in our novel PREP ligands? See the video below for more information!

NeuroPREP pitch fall 2020

This 5-minute video briefly outlines our research and provides details on how to progress the novel PREP ligands into clinical trials.


Recent news from PREP lab

@helsinkiuni @LifeSciHelsinki Artists, leave you contact details with this form to get further information!…

@helsinkiuni @LifeSciHelsinki Some more info about out #ArtMeetsScience project in this poster.

Artists based in (Southern) Finland: Join our #ArtMeetsScience project! Further info and link for signing up in the……

@MyohanenTimo @helsinkiuni Congratulations Tommi! Also thank you Ullamari Pesonen and Raimo Tuominen!